Additionally, the anti-angiogenic ECM glycoprotein TSP-1 is implicated in reducing cancer cell proliferation, survival as well as motility and is upregulated by p53 binding to the encoding THBS1 promoter region (84, 87, 88). This evidence concerns the gene TP53 and cancer.